InvestorsHub Logo
Followers 85
Posts 314
Boards Moderated 0
Alias Born 06/20/2020

Re: anarmyofme post# 53642

Sunday, 12/06/2020 7:40:34 PM

Sunday, December 06, 2020 7:40:34 PM

Post# of 198650
Monoclonal antibodies are a "disruptive" biotechnology. Big pharma probably trying to run out the clock on the patents while they made BILLIONS from toxic ARVs.

$ENZC CEO is a Big League Patent Lawyer and knows what they hold with #CLONE3 patented technology (including all related patents and foreign counterparts, as confirmed in Wednesday night's filing).

CEO Helped secure hundreds of Patents across a diverse array of important industries including Biotechnology, Aerospace, Electronics, Internet, Oil & Gas

$ENZC's patents include a "production methodology" & "proprietary cell lines"

Big pharma needs what $ENZC has. Remember, US Gov't tried to get the patent but Bioclonetics won.

https://twitter.com/UncleBillyMoney/status/1335744535062831107?s=20